Senescence β-Galactosidase Staining Kit #9860
Product Information
Protocol
Product Description
The Senescence β-Galactosidase Staining Kit is designed to conveniently provide reagents needed to detect β-galactosidase activity at pH 6, a known characteristic of senescent cells. Papers have published using this kit in both cells and frozen tissue. The kit includes all reagents necessary for this assay.
Background
Limited capacity to replicate is a defining characteristic of most normal cells and culminates in senescence, an arrested state in which the cell remains viable (1). Senescent cells are not stimulated to divide by serum or passage in culture, and senescence invokes a specific cell cycle profile that differs from most damage-induced arrest processes or contact inhibition (2). An enlarged cell size, expression of pH-dependent β-galactosidase activity (3), and an altered pattern of gene expression (4,5) further characterize senescent cells.
- Goldstein, S. (1990) Science 249, 1129-33.
- Sherwood, S. W. et al. (1988) Proc. Natl. Acad. Sci., USA 85, 9086-90.
- Dimri, G. et al. (1995) Proc. Natl. Acad. Sci., USA 92, 9363-7.
- Cristofalo, V. J. et al. (1998) Crit. Rev. Eukaryot Gene Expr. 8, 43-80.
- Linskens, M. H. et al. (1995) Nucleic Acid Res. 23, 3244-51.
Product Citations: 63
- Baker, D. J. et al. (2004) Nat. Genetics 36, 744-749.
- Su, D. et al. (2009) J Biol Chem 284, 12153-64.
- Swarbrick, A. et al. (2008) Proc Natl Acad Sci U S A 105, 5402-7.
- Efeyan, A. et al. (2007) Cancer Res 67, 7350-7.
- Boucher, M.J. et al. (2004) Am J Physiol Gastrointest Liver Physiol 286, G736-46.
- Efeyan, A. et al. (2009) PLoS One 4, e5475.
- Chang, C.J. et al. (2011) Nat Cell Biol 13, 317-23.
- Delmore, J.E. et al. (2011) Cell 146, 904-17.
- Blasco, R.B. et al. (2011) Cancer Cell 19, 652-63.
- Cronin, J.C. et al. (2013) Cancer Res 73, 5709-18.
- Pérez de Castro, I. et al. (2013) Cancer Res 73, 6804-15.
- Wang, M. et al. (2014) Cancer Res 74, 2825-34.
- Park, E. et al. (2013) Mol Cell 50, 908-18.
- Rader, J. et al. (2013) Clin Cancer Res 19, 6173-82.
- Guo, J.Y. et al. (2013) Genes Dev 27, 1447-61.
- Evangelou, K. et al. (2013) Cell Death Differ 20, 1485-97.
- Khongkow, P. et al. (2014) Oncogene 33, 4144-55.
- Flach, J. et al. (2014) Nature 512, 198-202.
- Tang, Y. et al. (2013) Oncogene 32, 2792-8.
- Agrelo, R. et al. (2013) Oncogene 32, 5492-500.
- Li, Z. et al. (2013) Oncotarget 4, 2532-49.
- Gagou, M.E. et al. (2014) Oncotarget 5, 11381-98.
- Zhou, Z.W. et al. (2013) PLoS Genet 9, e1003702.
- Sanchez, N. et al. (2013) PLoS One 8, e65671.
- Li, L.H. et al. (2014) PLoS One 9, e104203.
- Arason, A.J. et al. (2014) PLoS One 9, e88683.
- Krencik, R. et al. (2015) Sci Transl Med 7, 286ra66.
- Kovatcheva, M. et al. (2015) Oncotarget 6, 8226-43.
- Chen, R. et al. (2015) Oncotarget 6, 32841-55.
- Kannan, A. et al. (2016) Oncotarget 7, 6576-92.
- Havel, J.J. et al. (2015) Oncogene 34, 1487-98.
- Defamie, V. et al. (2015) Oncogene 34, 4098-108.
- Khongkow, P. et al. (2016) Oncogene 35, 990-1002.
- Castillo-Lluva, S. et al. (2015) Oncogene 34, 4777-90.
- Wan, Y. et al. (2015) J Cell Biol 209, 235-46.
- Yuan, Y. et al. (2016) J Biol Chem 291, 1307-19.
- Gabitova, L. et al. (2015) Cell Rep 12, 1927-38.
- Solovjeva, L. et al. (2015) BMC Mol Biol 16, 18.
- Chung, S.I. et al. (2016) Oncotarget 7, 7354-66.
- Lowe, D. et al. (2016) Oncotarget 7, 8524-31.
- Lee, H. et al. (2016) Oncotarget 7, 19134-46.
- Chang, J. et al. (2016) Nat Med 22, 78-83.
- Baker, D.J. et al. (2016) Nature 530, 184-9.
- Takai, H. et al. (2016) Genes Dev 30, 812-26.
- Borghesan, M. et al. (2016) Cancer Res 76, 594-606.
- De Amicis, F. et al. (2016) Oncotarget , 57955-57969.
- Oh, A.Y. et al. (2016) Cancer Res 76, 4791-804.
- Lawson, C.D. et al. (2016) Cancer Res 76, 3826-37.
- Liceras-Boillos, P. et al. (2016) Oncogene , .
- Sriraman, A. et al. (2016) Oncotarget 7, 31623-38.
- Lee, H. et al. (2016) Oncotarget 7, 19134-46.
- Lowe, D. et al. (2016) Oncotarget 7, 8524-31.
- Borghesan, M. et al. (2016) Cancer Res 76, 594-606.
- Yuan, Y. et al. (2016) J Biol Chem 291, 1307-19.
- Kannan, A. et al. (2016) Oncotarget 7, 6576-92.
- Shao, Z. et al. (2016) Nat Commun 7, 10869.
- Xiong, Z.M. et al. (2016) Aging Cell 15, 279-90.
- Soriano-Arroquia, A. et al. (2016) Aging Cell 15, 361-9.
- Llanos, S. et al. (2016) Nat Commun 7, 10438.
- Walter, D. et al. (2016) Nat Commun 7, 10530.
- Felsenstein, K.M. et al. (2016) ACS Chem Biol 11, 139-48.
- Frame, F.M. et al. (2016) Cancer Med 5, 61-73.
- Zhu, N. et al. (2016) Stem Cells Int 2016, 5687589.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意，否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件，除非书 CST 的合法授书代表以书面形式书独接受， 否书均被拒书，并且无效。
专品专有“专供研究使用”的专专或专似的专专声明， 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的， 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专，且专用于研专用途。将专品用于专断、专防或治专目的， 或专专售（专独或作专专成）或其他商专目的而专专专品，均需要 CST 的专独专可。客专：(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品，或使用专品制造任何商专专品，(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专，或使用专品开专任何与 CST 的专品或服专专争的专品或服专， (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专，(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品， (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.